Loading…
← CockpitCompetitor Analysis › VVVV vVARDIS Holding AG Class AOpen in the cockpit ↗

vVARDIS Holding AG Class AVVVVCompetitor analysis, valuation and peers

United States · USD·Health Care›Medical Specialties
Mkt cap
$594M
US dollars, full cap
$/day
$20.2M
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-114.0 pp
WACC 9.1%
Hurdle
n/a
no reverse DCF
Close · USD$15.47
1D-2.1%
1Wn/a
1Mn/a
3Mn/a
6Mn/a
YTDn/a
1Yn/a

What vVARDIS does

Employees: 137

vVARDIS at a glance

Size vVARDIS (VVVV) is a United States Health Care company (Medical Specialties) with a market value of $594M, the 2557th largest of 3,085 United States companies the cockpit tracks. Shares closed at $15.47 on 18 Nov 2026.

Growth Revenue grew 148.5% over the last twelve months (peer median +14.4%); the operating margin is -71.6% (peer median 8.5%).

Valuation It trades at 14.3× enterprise value to sales against a peer median of 3.8× (2nd most expensive of 20).

Capital Return on invested capital runs 114.0 points below its cost of capital (9.1% WACC).

vVARDIS financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024
Revenue$49.7M$30.2M$12.2M
Revenue growth—+148%—
Gross profit$38.0M$18.7M$3.91M
EBITDA-$31.1M-$38.1M-$27.1M
Net income-$52.2M-$56.5M-$34.7M
Free cash flow-$10.6M-$17.1M-$23.8M
Capital expenditure$2.56M$2.81M$325,000
Total debtn/a$107M$73.0M

Quarterly statements and history in the cockpit →

vVARDIS competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Fundamentals: revenue growth against valuation

0%+250%+500%+750%+1,000%5×10×15×TCMD688581SGHTMEDI300314NANOBIO6882366031224728QDELVVVVRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. vVARDIS is the large dot.

vVARDIS competitors and peer comparison

How vVARDIS compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

vVARDIS against its 20 peers (data as of 18 Nov 2026)
MeasureVVVVPeer medianRank in peer set
Revenue growth (TTM)+148.5%+14.4%2nd highest of 20
Operating margin-71.6%8.5%3rd lowest of 20
EV / Sales14.3×3.8×2nd most expensive of 20
ROIC minus cost of capital-114.0 pp+1.7 pp2nd lowest of 19

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
vVARDIS VVVVUnited States$594Mn/a+148%-72%14.3×n/an/a
Sahajanand Medical Technologies SMT.NSIndia$595Mn/an/an/an/an/an/a
Tactile Systems Technology TCMDUnited States$592M+6%+14%9%1.5×8.4%+12.0%
Hangzhou AGS MedTech 688581.SSChina$590M-22%-18%33%3.7×0.4%+27.8%
Sight Sciences SGHTUnited States$599M+122%+16%-30%6.4×n/an/a
Medistim MEDI.OLNorway$599M+32%+19%29%7.1×-1.2%+14.5%
Ningbo David Medical Device 300314.SZChina$589M+25%+19%11%5.4×n/an/a
Nanosonics NAN.AXAustralia$599M-4%+3%7%3.8×35.3%+6.7%
Orchestra BioMed OBIOUnited States$587M+87%+1,007%-195%18.3×n/an/a
Xvivo Perfusion XVIVO.STSweden$611M-32%+18%12%6.3×35.9%+35.2%
Jiangsu Hanvo Safety Product 300952.SZChina$575M-38%+6%8%3.3×n/an/a
Pacific Biosciences of California PACBUnited States$573M+54%+4%-98%6.7×n/an/a
Beijing Chunlizhengda Medical Instruments 688236.SSChina$618M-27%-13%31%2.1×-8.5%+2.2%
Wuhan Huakang Century Clean Technology 301235.SZChina$563M-57%+28%7%1.6×n/an/a
Cowealth Medical China 603122.SSChina$562M-34%-18%-5%5.9×n/an/a
SunMax Biotechnology 4728.TWOTaiwan$630M0%+19%51%8.3×-2.6%+18.8%
AK Medical 1789.HKHong Kong$642M-23%+16%26%2.1×-11.5%+6.7%
Contec Medical Systems 300869.SZChina$547M-26%-2%-16%5.5×15.0%-19.8%
Zhejiang Gongdong Medical Technology 605369.SSChina$542M-21%+6%9%2.6×10.2%+6.5%
QuidelOrtho QDELUnited States$657M-20%-5%-2%1.4×n/an/a
Synektik SNT.WAPoland$662M+10%+32%24%2.9×0.2%+47.5%

Questions

Which companies are vVARDIS's closest peers?
The cockpit's peer set: Sahajanand Medical Technologies (SMT.NS), Tactile Systems Technology (TCMD), Hangzhou AGS MedTech (688581.SS), Sight Sciences (SGHT), Medistim (MEDI.OL), Ningbo David Medical Device (300314.SZ), Nanosonics (NAN.AX), Orchestra BioMed (OBIO).
Is vVARDIS expensive compared with its peers?
On ev / sales it trades at 14.3× against a peer median of 3.8×, 2nd most expensive of 20 in its peer set.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.